Clinical Trial Search

Primary: Number of Participants in Population 1 With a Clinical Response at Week 8 — 13; 12; 8; 13 participants — p=0.337

Primary: Performance on the Cambridge Neuropsychological Test Automated Battery (CANTAB) - RVIP Reaction Time — 407.7; 476.8; 427.4; 379.2 milliseconds — p=0.006

Primary: Plasma Dopa 1 hr After Breakfast — 11670; 1705 pg/mL

Primary: Calcium Balance — 61; 508 mg/d calcium

Primary: Change in Glcosylated Hemoglobin (HbA1c) — 8.59; 8.65; -0.98; -0.88 percentage — p=0.2534

Primary: Area Under the Curve (AUC) of PEG-Intron at 12 Weeks — 235000 pg*hr/mL

Primary: Overall Improvement in Periorbital Wrinkles and Rhytids Around the Eyes — 47; 50 percentage of participants improved

Primary: Mean Change From Baseline in Clinic Visit Trough (Pre-bronchodilator and Pre-dose) Forced Expiratory Volume in One Second (FEV1) at Week 12 — 0.196; 0.332; 0.368 Liters…

Primary: Number of Evaluable Participants With Complete Response (CR) and Partial Response (PR) at One Year — 0; 1 participants

Primary: Change From Baseline of Chamomile Extract on Measures of Sleep at Day 28. — 83.3; 77.5 percentage of time asleep — p=0.21

Primary: Tumor Response, Defined by Disease: Chronic Lymphocytic Leukemia(CLL): Clinical Complete or Complete or Nodular Partial or Partial Remission, Waldenstrom: Complete or…

Primary: Spirometric FVC Values at Baseline — 2.74; 3.07 Liters

Primary: Plaque Index of Test Mouth Rinse Versus Sterile Water After Day 4 of Treatment Administration — 3.03; 3.23 Score on a scale — p=0.0915

Primary: Change From Baseline in Endurance Time (Seconds) — 68.3; 9.8 Seconds

Primary: Lumbar Spine Bone Mineral Density Percent Change From Parent Study 20010223 Baseline to Year 8 — 8.4; 11.2; 11.0; 16.5 percent